These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12353189

  • 1. Valacyclovir in the treatment of facial herpes simplex virus infection.
    Laiskonis A, Thune T, Neldam S, Hiltunen-Back E.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S66-70. PubMed ID: 12353189
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM.
    Sex Transm Dis; 2008 Jul 01; 35(7):668-73. PubMed ID: 18461016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 01; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 7. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH, Warren T, Werner M, Phillips JA.
    Sex Transm Dis; 2007 Jun 01; 34(6):339-43. PubMed ID: 17065847
    [Abstract] [Full Text] [Related]

  • 8. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C, McKeough M, Sebastian K, Kriesel J, Spruance S.
    J Eur Acad Dermatol Venereol; 2009 Mar 01; 23(3):263-7. PubMed ID: 19143902
    [Abstract] [Full Text] [Related]

  • 9. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M.
    Bone Marrow Transplant; 2003 Jan 01; 31(1):51-5. PubMed ID: 12621507
    [Abstract] [Full Text] [Related]

  • 10. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K.
    Arch Intern Med; 2003 Jan 01; 156(15):1729-35. PubMed ID: 8694673
    [Abstract] [Full Text] [Related]

  • 11. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY, Topical Penciclovir Clinical Study Group.
    J Dermatolog Treat; 2002 Jun 01; 13(2):67-72. PubMed ID: 12060504
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
    Aurelius E, Franzen-Röhl E, Glimåker M, Akre O, Grillner L, Jorup-Rönström C, Studahl M, HSV-2 Meningitis Study Group.
    Clin Infect Dis; 2012 May 01; 54(9):1304-13. PubMed ID: 22460966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 18. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

  • 19. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S.
    J Infect Dis; 2008 May 01; 197(9):1289-95. PubMed ID: 18422441
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.